Moreover, the circulating levels of miR-133a were significantly enhanced in AMI patients compared to coronary heart disease and myocardial ischemia patients, presenting a similar trend as plasma cTnI concentration. The gene discussed is TNNI3; the disease is coronary artery disorder.